Over the last few decades, the incidence and prevalence of urological conditions, such as chronic kidney disease (CKD), end-stage renal disease (ESRD), urinary incontinence, kidney and ureteral stones, and bladder and prostate cancer, have increased significantly across the globe. According to the Global Forum on Incontinence, 4−8% of the global population (approximately 400 million people) were affected by urinary incontinence in 2018. Urology-related consumables such as urinary catheters are used to manage incontinence, which cannot be treated or managed with medicines or surgery. The prevalence of urinary incontinence is expected to grow due to the growing aging population and the increasing incidence of obesity, as these are the two major risk factors for urinary incontinence. This is expected to fuel the market growth.

The global urology devices market is projected to reach USD 46.4 billion by 2026 from USD 38.0 billion in 2021, at a CAGR of 4.1%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173062212

KEY MARKET DYNAMICS

1 DRIVERS
1 Rising incidence and prevalence of urological conditions
2 Growing preference for minimally invasive procedures
3 Growing number of hospitals and investments in endoscopy and laparoscopy facilities
2 RESTRAINTS
1 High degree of consolidation
2 High cost of urology devices
3 OPPORTUNITIES
1 Emerging markets offer lucrative opportunities
Market Segmentation:
The urology devices market is segmented into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other applications based on application. In 2020, the urological cancer and BPH segment accounted for the highest growth rate.

Based on product, the market is segmented into instruments and consumables & accessories. The instruments segment accounted for the largest share of the market in 2020. This segment includes dialysis devices, endoscopes, laser and lithotripsy devices, robotic systems, endovision and imaging systems, insufflators, endoscopy fluid management systems, and urodynamic systems.

Based on end users, the market is segmented into hospitals, ASCs, and clinics; dialysis centers; and home care settings. In 2020, the hospitals, ASCs, and clinics segment accounted for the largest share of the market.

Regional Analysis:
The Urology Devices market is segmented into five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the urology devices market.

Recent Developments
• In November 2020, Baxter International Inc. (US) received 510(k) approval from the FDA for its Homechoice Claria automated peritoneal dialysis system with the Sharesource connectivity platform.
• In May 2019, Fresenius Medical Care AG & Co. KGaA (Germany) announced the establishment of a new distribution center in Knoxville, Tennessee. This expansion will support the delivery of products needed for in-center hemodialysis treatment.
• In February 2019, Fresenius Medical Care AG & Co. KGaA (Germany) acquired NxStage Medical, Inc. (US) to widen its product portfolio in the areas of renal and critical care.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=173062212

Top Key Players:-
The major players operating in this urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), Stryker Corporation (US), KARL STORZ (Germany), Cook Medical (US), Intuitive Surgical (US), Medtronic plc (Ireland), Cardinal Health (US), Teleflex Incorporated (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Balton Sp. z o.o. (Poland), Dialife SA (Switzerland), Maxer Endoscopy GmbH (Germany), Vimex Sp. z o.o. (Poland), Amsino International, Inc. (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Medispec (US), Medical Technologies of Georgia (Georgia), EndoMed Systems GmbH (Germany), Hunter Urology (England), J and M Urinary Catheters LLC (US), and Ribbel International Limited (India).